Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations
Eli Lilly and Company
Eli Lilly and Company
Genmab
Bristol-Myers Squibb
Toray Industries, Inc
NGM Biopharmaceuticals, Inc
Eli Lilly and Company
Eli Lilly and Company
Dartmouth-Hitchcock Medical Center